AbbVie is a pharmaceutical firm with a strong exposure to immunology (with Humira, Skyrizi, and Rinvoq) and oncology (with Imbruvica and Venclexta). The company was spun off from Abbott in early 2013. …
Swipe sideways for all columns
| Quarter | Date | EPS Est | EPS Act | Surprise | EPS YoY | Rev Est | Rev Act | Rev YoY |
|---|